Inventor · disambiguated record
Zhiming Liao
Also filed as: LIAO ZHIMING
18 granted patents·3 pending applications·26 citations·filing 2009–2023
91Inventor score
Top patents by PatentIndex Score
21 records- 0192US10689445B2Anti-PD-L1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2017·Granted Jun 23, 2020·6 cites·28 claims
- 0291US9885721B2PD-L1 antibodies and uses thereofSPRING BIOSCIENCE CORP·Filed 2015·Granted Feb 6, 2018·5 cites·12 claims
- 0387US11719699B2Antibodies, compositions, and immunohistochemistry methods for detecting C4.4aVENTANA MED SYST INC·Filed 2021·Granted Aug 8, 2023·1 cites·15 claims
- 0487US10852304B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2017·Granted Dec 1, 2020·3 cites·19 claims
- 0586US10948493B2Antibodies, compositions, and immunohistochemistry methods for detecting C4.4aVENTANA MED SYST INC·Filed 2017·Granted Mar 16, 2021·2 cites·20 claims
- 0686US10775383B2PD-L1 antibodies and uses thereofVENTANA MED SYST INC·Filed 2017·Granted Sep 15, 2020·2 cites·15 claims
- 0783US10501544B2Anti-B7-H3 antibodies and diagnostic uses thereofSPRING BIOSCIENCE CORP·Filed 2016·Granted Dec 10, 2019·4 cites·24 claims
- 0882US12419201B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2023·Granted Sep 23, 2025·0 cites·25 claims
- 0978US11002738B2Anti-GPNMB antibodies and diagnostic uses thereofSPRING BIOSCIENCE CORP·Filed 2018·Granted May 11, 2021·1 cites·18 claims
- 1078US2023159641A1Anti-pd-l1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 1172US11525003B2Anti-B7-H3 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2019·Granted Dec 13, 2022·0 cites·19 claims
- 1271US11747339B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2020·Granted Sep 5, 2023·0 cites·20 claims
- 1371US11530269B2Anti-PD-L1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2020·Granted Dec 20, 2022·0 cites·20 claims
- 1470US10823734B2Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2019·Granted Nov 3, 2020·0 cites·15 claims
- 1566US9040667B2Antibody cocktailLIAO ZHIMING·Filed 2010·Granted May 26, 2015·2 cites·18 claims
- 1661US10436785B2Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereofSPRING BIOSCIENCE CORP·Filed 2016·Granted Oct 8, 2019·0 cites·15 claims
- 1755US10975157B2Anti-OX40 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2018·Granted Apr 13, 2021·0 cites·24 claims
- 1853US9778262B2Antibody cocktailDAKO DENMARK AS·Filed 2015·Granted Oct 3, 2017·0 cites·13 claims
- 1950US2012003664A1Method for evaluating pre-treatmentLOVBORG UFFE·Filed 2009·Application pending·0 cites
- 2049US9075065B2Prostate cancer biomarkerLIAO ZHIMING·Filed 2009·Granted Jul 7, 2015·0 cites·6 claims
- 2148US2016009805A1Anti-pd-l1 antibodies and diagnostic uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhiming Liao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →